American Conference
Institute (ACI) will be holding its 13th Advanced Forum on Structuring,
Negotiating, and Managing Pharma/Biotech Collaborative Agreements from November
17-18, 2009 in New York, NY.  The
conference will allow attendees to:

• Integrate
emerging trends in investment capital and current deal structuring into product
strategies;
• Establish a
strong presence in new and emerging markets;
• Strengthen market
power by ensuring effective due diligence;
• Maximize
profitability through skillful negotiations of critical performance terms;
• Develop
strategies to determine the impact of M&A activity and best position a
company for an acquisition;
• Gain greater
control by drafting clearly defined termination provisions;
• Ensure effective
alliance management; and
• Protect future
rights on emerging technologies such as follow-on biologics.

In particular,
ACI's faculty will offer presentations on the following topics:

• Predicting future
trends and reviewing emerging strategies from the year's top deals;
• Setting the
stage:  Conducting effective and
strategic due diligence;
• Negotiating
essential critical terms with built-in milestones to maximize profitability;
• Integrating
M&A considerations into a collaborations strategy;
• Creating and
implementing critical termination provisions;
• Establishing
governance structures for successful alliance management;
• Negotiating
collaborative research agreements with the U.S. government and academic institutions;
and
• Anticipating
future technologies and incorporating terms into the agreement to protect
future rights.

Two additional
post-conference master classes will be offered on November 19, 2009.  The first mast class, entitled:  "International Collaborative
Agreements:  Navigating and
Managing the Unique Regulatory and Legal Risks of Global Partnerships,"
will be offered from 9:00 am to 12:00 pm, and will provide information
concerning specific legal contractual nuances of India, Asia, and the EU, as
well as avoiding invalidation of restrictive terms, minimizing tax liability,
and negotiating alliances with foreign academic institutions.  The second master class, entitled
"The 'Win-Win' Collaborative Agreement:  Practical and Ethical Negotiating and Drafting
Strategies," will be offered from 2:00 pm to 5:00 pm, and will provide insights
that attendees can implement into future agreementa to achieve a win-win
successful alliance.

The agenda for the
Pharma/Biotech Collaborative Agreements conference can be found here.  A complete brochure for this
conference, including an agenda, list of speakers, and registration form can be
downloaded here.

The registration
fees for the conference and master classes are as follows:  $2,195 (conference alone), $2,795
(conference and one master class), and $3,395 (conference and both master
classes).  Those registering on or
before September 18, 2009 will receive a $300 discount off the registration fee
and those registering on or before October 23, 2009 will receive a $200
discount off the registration fee. 
Those interested in registering for the conference can do so here, by calling
1-888-224-2480, or by faxing a registration form to 1-877-927-1563.